Ecolab director granted 1,269 stock options
Ecolab Inc. director Julie Whalen reported new equity awards in the form of non-employee director stock options.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Ecolab Inc. director Julie Whalen reported new equity awards in the form of non-employee director stock options. She received two option grants covering a total of 1,269 shares of common stock at an exercise price of $247.70 per share, with staged vesting over four three-month periods and full acceleration upon a qualifying change in control. Following these awards, she also reports direct ownership of 341.03 shares of common stock.
Insider Trade Summary
Grant/Award: 1,269 shares
Grant/Award
3 txns
Insider
Whalen Julie
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Employee Director Stock Option (Right to Buy) | 732 | $0.00 | $0.00 |
| Grant/Award | Non-Employee Director Stock Option | 537 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Non-Employee Director Stock Option (Right to Buy) — 732 contracts (Direct);
Non-Employee Director Stock Option — 537 contracts (Direct);
Common Stock — 341.03 shares (Direct)
Footnotes (1)
- F1. The option will become exercisable, on a cumulative basis, as to 25% of the option shares (excluding any fractional portion less than one share), on the last day of each of the first, second and third three-month periods following its date of grant and as to the remaining shares on the earlier of the last day of the fourth three-month period following its date of grant or the company's next annual meeting date; provided, however, that if a Change in Control of the Company (as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan) will occur, then the option will become immediately exercisable in full. The date listed in the Date Exercisable column represents the first vesting date.
Key Figures
Common stock held: 341.03 shares
Option grant 1 size: 537 shares
Option grant 2 size: 732 shares
+3 more
6 metrics
Common stock held
341.03 shares
Direct common stock ownership following transactions
Option grant 1 size
537 shares
Non-Employee Director Stock Option, underlying common shares
Option grant 2 size
732 shares
Non-Employee Director Stock Option (Right to Buy), underlying common shares
Option exercise price
$247.70 per share
Conversion/exercise price for both option grants
Total option shares granted
1,269 shares
Sum of underlying common shares across both new option awards
Option expiration date
May 15, 2036
Expiration for both non-employee director stock option grants
Key Terms
Non-Employee Director Stock Option, Non-Employee Director Stock Option (Right to Buy), Change in Control, Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan, +1 more
5 terms
Non-Employee Director Stock Option financial
"security_title: "Non-Employee Director Stock Option""
Non-Employee Director Stock Option (Right to Buy) financial
"security_title: "Non-Employee Director Stock Option (Right to Buy)""
Change in Control financial
"if a Change in Control of the Company... will occur, then the option will become immediately exercisable"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan financial
"as that term is defined in the Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation Plan"
vesting financial
"The option will become exercisable, on a cumulative basis, as to 25% of the option shares... following its date of grant"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Ecolab (ECL) director Julie Whalen report?
Julie Whalen reported receiving two non-employee director stock option grants and updated her direct common stock holdings. The options cover 1,269 underlying shares at an exercise price of $247.70 per share, and she reports 341.03 common shares owned directly after these awards.
What is the exercise price and term of Julie Whalen’s Ecolab (ECL) stock options?
Each option grant has an exercise price of $247.70 per share and expires on May 15, 2036. This means Whalen can choose to exercise the options at that fixed price any time after vesting and before the expiration date, subject to plan terms.
When do Julie Whalen’s Ecolab (ECL) director stock options vest?
The options vest in four installments following the grant date. They become exercisable as to 25% of the shares after each of the first three three-month periods, with the remaining shares vesting after the fourth such period or at the company’s next annual meeting, whichever occurs earlier.
What happens to Julie Whalen’s Ecolab (ECL) options if there is a change in control?
The footnote states that upon a qualifying Change in Control of Ecolab, the option becomes immediately exercisable in full. This acceleration provision means all remaining unvested option shares would vest at that time under the plan’s definition of change in control.
AI-generated analysis. How Rhea-AI works. Not financial advice.
